Protein kinase A determines platelet life span and survival by regulating apoptosis

Journal of Clinical Investigation

Volumn 127, Issue 12, 2017, Pages 4338-4351

  Zhao, Lili ^a   Liu, Jun ^a   He, Chunyan ^b   Yan, Rong ^a   Zhou, Kangxi ^a   Cui, Qingya ^a   Meng, Xingjun ^a   Li, Xiaodong ^a   Zhang, Yang ^a   Nie, Yumei ^a   Hu, Renping ^a   Liu, Yancai ^a   Zhao, Lian ^a,b   Chen, Mengxing ^a   Xiao, Weiling ^a   Tian, Jingluan ^a   Zhao, Yunxiao ^a   Cao, Lijuan ^a   Zhou, Ling ^a   Lin, Anning ^c   Ruan, Changgeng ^a   Dai, Kesheng ^a   more..

^a SOOCHOW UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN BAD; PROTEIN BCL XL; SERINE; BCL2L1 PROTEIN, HUMAN; BCL2L1 PROTEIN, MOUSE; PROTEIN BCL X;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SEPSIS; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; ANIMAL; DISEASE MODEL; ENZYMOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; THROMBOCYTE;

ANIMALS; APOPTOSIS; BACTERIAL INFECTIONS; BCL-X PROTEIN; BLOOD PLATELETS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 85037092279     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI95109     Document Type: Article

References (53)

1. Leeksma CH, Cohen JA. Determination of the life of human blood platelets using labelled diisopropylfluorophosphanate. Nature. 1955;175(4456):552–553.
2. Yeh JJ, Tsai S, Wu DC, Wu JY, Liu TC, Chen A. P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection. Blood. 2010;115(21):4247–4253.
3. Gafter-Gvili A, et al. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc. 2011;86(5):389–396.
4. Goette NP, et al. Platelet apoptosis in adult immune thrombocytopenia: insights into the mechanism of damage triggered by autoantibodies. PLoS One. 2016;11(8):e0160563.
5. Tang WH, et al. Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets. Circulation. 2014;129(15):1598–1609.
6. Mason KD, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173–1186.
7. Li S, et al. The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost. 2010;8(2):341–350.
8. Kodama T, et al. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. JBiolChem. 2011;286(16):13905–13913.
9. Kelly PN, et al. Individual and overlapping roles of BH3-only proteins Bim and Bad in apoptosis of lymphocytes and platelets and in suppression of thymic lymphoma development. CellDeath Differ. 2010;17(10):1655–1664.
10. Niswender CM, Ishihara RW, Judge LM, Zhang C, Shokat KM, McKnight GS. Protein engineering of protein kinase A catalytic subunits results in the acquisition of novel inhibitor sensitivity. JBiolChem. 2002;277(32):28916–28922.
11. Skålhegg BS, Huang Y, Su T, Idzerda RL, McKnight GS, Burton KA. Mutation of the Calpha subunit of PKA leads to growth retardation and sperm dysfunction. MolEndocrinol. 2002;16(3):630–639.
12. Hanoune J, Defer N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol. 2001;41:145–174.
13. Omori K, Kotera J. Overview of PDEs and their regulation. Circ Res. 2007;100(3):309–327.
14. Insel PA, Zhang L, Murray F, Yokouchi H, Zam-bon AC. Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger. Acta Physiol (Oxf). 2012;204(2):277–287.
15. Keshwani MM, et al. Mechanisms of cyclic AMP/protein kinase A- and glucocorticoid-mediated apoptosis using S49 lymphoma cells as a model system. Proc Natl Acad Sci U S A. 2015;112(41):12681–12686.
16. Beck F, et al. Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood. 2014;123(5):e1–e10.
17. Raslan Z, Naseem KM. The control of blood platelets by cAMP signalling. Biochem Soc Trans. 2014;42(2):289–294.
18. Bergmeier W, et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. Blood. 2003;102(12):4229–4235.
19. Pereira J, et al. Platelet aging in vivo is associated with activation of apoptotic pathways: studies in a model of suppressed thrombopoiesis in dogs. ThrombHaemost. 2002;87(5):905–909.
20. Bodnar RJ, Xi X, Li Z, Berndt MC, Du X. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta). JBiolChem. 2002;277(49):47080–47087.
21. Jackson SP, Schoenwaelder SM. Procoagulant platelets: are they necrotic? Blood. 2010;116(12):2011–2018.
22. Petros S, Kliem P, Siegemund T, Siegemund R. Thrombin generation in severe sepsis. Thromb Res. 2012;129(6):797–800.
23. Tripodi A, et al. Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. JThrombThromboly-sis. 2011;31(2):165–172.
24. Álvarez-Román MT, et al. Procoagulant profile in patients with immune thrombocytopenia. Br J Haematol. 2016;175(5):925–934.
25. Jantzen HM, Milstone DS, Gousset L, Conley PB, Mortensen RM. Impaired activation of murine platelets lacking G alpha(i2). J Clin Invest. 2001;108(3):477–483.
26. Zhang W, Colman RW. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phos-phodiesterase 3A. Blood. 2007;110(5):1475–1482.
27. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6(5):513–519.
28. Leytin V, Allen DJ, Mutlu A, Gyulkhandanyan AV, Mykhaylov S, Freedman J. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. LabInvest. 2009;89(4):374–384.
29. Schoenwaelder SM, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663–666.
30. Leytin V. Apoptosis in the anucleate platelet. BloodRev. 2012;26(2):51–63.
31. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol. 2007;7(12):964–974.
32. Elliott MR, Ravichandran KS. The dynamics of apoptotic cell clearance. Dev Cell. 2016;38(2):147–160.
33. Moujalled D, et al. Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein Bim. EMBORep. 2011;12(1):77–83.
34. Naderi EH, Jochemsen AG, Blomhoff HK, Naderi S. Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2. Neoplasia. 2011;13(7):653–663.
35. Mihara M, et al. p53 has a direct apoptogenic role at the mitochondria. MolCell. 2003;11(3):577–590.
36. Datta SR, et al. 14-3-3 proteins and survival kinas-es cooperate to inactivate BAD by BH3 domain phosphorylation. MolCell. 2000;6(1):41–51.
37. Lizcano JM, Morrice N, Cohen P. Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J. 2000;349(Pt 2):547–557.
38. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 1995;80(2):285–291.
39. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996;87(4):619–628.
40. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood. 2000;96(7):2520–2527.
41. Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Regulating billions of blood platelets: gly-cans and beyond. Blood. 2015;126(16):1877–1884.
42. Li J, et al. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia. Nat Com-mun. 2015;6:7737.
43. Dutta-Roy AK, Sinha AK. Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. JBiolChem. 1987;262(26):12685–12691.
44. Lucas FV, Skrinska VA, Chisolm GM, Hesse BL. Stability of prostacyclin in human and rabbit whole blood and plasma. ThrombRes. 1986;43(4):379–387.
45. Adams JM, et al. Subversion of the Bcl-2 life/death switch in cancer development and therapy. Cold Spring Harb Symp Quant Biol. 2005;70:469–477.
46. Canault M, et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood. 2010;115(9):1835–1842.
47. Chen W, et al. Inhibiting GPIbα shedding preserves post-transfusion recovery and hemostatic function of platelets after prolonged storage. Arte-rioscler Thromb Vasc Biol. 2016;36(9):1821–1828.
48. van der Wal DE, et al. Arachidonic acid depletion extends survival of cold-stored platelets by interfering with the [glycoprotein Ibα-14-3-3ζ] association. Haematologica. 2012;97(10):1514–1522.
49. Gitz E, et al. Improved platelet survival after cold storage by prevention of glycoprotein Ibα clustering in lipid rafts. Haematologica. 2012;97(12):1873–1881.
50. van der Wal DE, Du VX, Lo KS, Rasmussen JT, Verhoef S, Akkerman JW. Platelet apoptosis by cold-induced glycoprotein Ibα clustering. JThrombHaemost. 2010;8(11):2554–2562.
51. Kramer RM, et al. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. JBiolChem. 1996;271(44):27723–27729.
52. Stasi R, Evangelista ML, Stipa E, Buccisano F, Venditti A, Amadori S. Idiopathic thrombocytopenic purpura: current concepts in patho-physiology and management. ThrombHaemost. 2008;99(1):4–13.
53. Ranger AM, et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci U S A. 2003;100(16):9324–9329.